Himil Mahadevia, PGY-3 IM resident at UMKC, shared a post on X:
“Glad to share our research project related to immunotherapy was accepted for poster presentation at SITC (Society for Immunotherapy of Cancer) 2024 !!
Congratulations to all co-authors !!”
Source: Himil Mahadevia/X
Himil Mahadevia is a Resident Physician at the University of Missouri-Kansas City and a Research Collaborator at Mayo Clinic. Previously, he was a Clinical Extern at Houston Methodist and at the Swedish Hospital. He graduated from B.J. Medical College Ahmedabad, India.